3rd Quarter - Report — CROHN'S & COLITIS FOUNDATION for CROHN'S & COLITIS FOUNDATION (2025)

Firm

CROHN'S & COLITIS FOUNDATION

Client

CROHN'S & COLITIS FOUNDATION

Income

—

Expenses

$40,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.1 - Cuts to Federal funding for Medicaid and ACA plans FY 2026 Funding for medical research at the NIH and CDC FY 2025 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies

Lobbyist	Covered position, as disclosed
ERIN HENNESSEY MCKEON	—

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (119th), H.R. 5509 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.